Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias.
Alzheimer's disease and related dementias (ADRD) affect over 55 million globally. Current clinical trials suffer from low recruitment rates, a challenge potentially addressable via natural language processing (NLP) technologies for researchers to effectively identify eligible clinical trial participants.
Author(s): Idnay, Betina, Liu, Jianfang, Fang, Yilu, Hernandez, Alex, Kaw, Shivani, Etwaru, Alicia, Juarez Padilla, Janeth, Ramírez, Sergio Ozoria, Marder, Karen, Weng, Chunhua, Schnall, Rebecca
DOI: 10.1093/jamia/ocae032